Novel RAF/MEK inhibitor CH5126766/VS-6766 has efficacy in combination with eribulin for the treatment of triple-negative breast cancer.
Cancer Sci
; 112(10): 4166-4175, 2021 Oct.
Article
in En
| MEDLINE
| ID: mdl-34288272
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Proto-Oncogene Proteins c-raf
/
Coumarins
/
Mitogen-Activated Protein Kinase Kinases
/
Protein Kinase Inhibitors
/
Triple Negative Breast Neoplasms
/
Furans
/
Ketones
Limits:
Animals
Language:
En
Journal:
Cancer Sci
Year:
2021
Document type:
Article
Affiliation country:
Japón